CNIO Friends welcomes Víctor Frankenstein La investigacion es cosa de todos CNIO ARTE: Chema Madoz and Ignacio Cirac

Home | News | Publications


Mouse lymph node Innovation
Journal of Experimental Medicine. CNIO researchers assess melanoma progression with a new liquid biopsy technique When the surgeon surgically removes a melanoma, some patients are said to be ‘cancer-free’ and...
CNIO building Basic Research
Cancer Cell. CNIO researchers succeed at removing some types of pancreatic cancer in animal models Researchers from the Experimental Oncology Group, led by Mariano Barbacid at the Spanish National...
DLST protein Innovation
The American Journal of Human Genetics. CNIO researchers identify a new gene involved in the development of a rare endocrine tumour Paragangliomas and phaeochromocytomas are very rare neuroendocrine tumours: there are only 3-8 cases...
FAK activates cell migration Basic Research
PNAS. An international study co-led by CNIO identifies a ‘sensor’ that activates cell migration The cytoskeleton is a structure that not only helps cells maintain their shape and internal...
Elena Castro and David Olmos Translational
Journal of Clinical Oncology. CNIO researchers confirm links between aggressive prostate cancer and hereditary breast cancer Aggressive prostate cancer, one of the leading causes of cancer deaths in men, is associated with...
p62 Basic Research
Cancer Cell. Researchers from the CNIO and the Hospital 12 de Octubre make sense out of the chaos of melanoma Unlike other skin cancers – and without knowing really why – melanoma is one of the most...
Mielofibrosis Translational
Haematologica. The CNIO and Hospital 12 de Octubre find a potential new combination therapy against a rare disease of the bone marrow Myelofibrosis is a severe and very rare haematological disease for which treatment has only been...
Lung Cancer Clinical Research Unit H12O-CNIO Innovation
The New England Journal of Medicine (NEJM). An international clinical trial extends the effectiveness of immunotherapy to more lung cancer patients The strategy for triggering the patient’s own immune system to attack cancer, immunotherapy, is...
H12O-CNIO Haematological Malignancies Clinical Research Unit Innovation
Haematologica. A new methodology predicts the risk of relapse in patients with acute myeloid leukemia The acute myeloid leukemia (AML) is the most common haematological cancer in adults. With a 5-year...